| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| CD55 | Human CD55 / DAF Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $285.00 100ug | ||
| CD55 | Avitag CD5-H82E4 | Biotinylated Human CD55 / DAF Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Gebasaxturev | V-937; CVA-21 | Phase 2 Clinical | Viralytics Ltd | Breast Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Prostatic Neoplasms; Urinary Bladder Neoplasms | Details |
| PAT-SC1 | SC-1; PAT-SC1; PAT-SC-1 | Phase 2 Clinical | Oncomab Gmbh | Stomach Neoplasms | Details |
| Recombinant coxsackievirus B3 | Phase 1 Clinical | Wuhan Boweid Biotechnology Co Ltd | Neoplasms | Details |